1-4 of 4
Davide Bedognetti
Close
Sort by
Journal Articles

Immuno-AML, a Novel Immunogenomic Classifier Predicting Chemotherapy Response in Pediatric Patients with AML

Aesha Ibrahim Khalel Ali, Darawan Rinchai, Sara Deola, Mohammed Elanbari, Dhanya Kizhakayil, Shimaa Mohammed Sherif Khedr, Mohammed Toufiq, Tommaso Mina, Kulsoom Ghias, Zehra Fadoo, Sheanna M. Herrera, Che-Ann Lachica, Blessing Dason, Anila Ejaz, Elkhansa E. Elgaali, Ayman Saleh, Davide Bedognetti, Chiara Cugno
Journal: Blood
Blood (2022) 140 (Supplement 1): 11420–11422.
https://doi.org/10.1182/blood-2022-158970
Published: 2022
Journal Articles

Seasonal and pandemic (A/H1N1 2009) MF-59–adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens

Davide Bedognetti, Filippo Ansaldi, Elisa Zanardi, Paolo Durando, Mario Roberto Sertoli, Carlotta Massucco, Enrico Balleari, Omar Racchi, Gabriele Zoppoli, Andrea Orsi, Cristiano Alicino, Giancarlo Icardi, Francesco M. Marincola, Simonetta Zupo, Manlio Ferrarini, Andrea De Maria
Journal: Blood
Blood (2012) 120 (9): 1954–1957.
https://doi.org/10.1182/blood-2012-06-438689
Published: 2012
Journal Articles

Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells.

Davide Bedognetti, MD, Gabriele Zoppoli, MD, Carlotta Massucco, Simonetta Zupo, Mario Roberto Sertoli, MD, Manlio Ferrarini, MD, Elisa Zanardi, MD, Nicoletta Provinciali, MD, Guido Siffredi, MD, Graziano Caltabiano, MD, Riccardo Ghio, MD, Alessio Nencioni, MD, Marco Messina, MD, Omar Racchi, MD, Andrea Bruzzone, MD, Marianna Sabatino, MD, Francesco M. Marincola, MD, Maria Libera Ascierto, Lorenzo Uccellini, Pos Zoltan, PhD, Filippo Ansaldi, Andrea De Maria, MD
Journal: Blood
Blood (2009) 114 (22): 936.
https://doi.org/10.1182/blood.V114.22.936.936
Published: 2009
Journal Articles

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Gabriele Zoppoli, MD, Michele Cea, MD, Floriana Fruscione, Santina Bruzzone, Ph.D., Debora Soncini, Davide Bedognetti, MD, Eva Moran, Ph.D., Enrico Balleari, MD, Andrea Bruzzone, MD, Anna Garuti, Gabriella Cirmena, Ilaria Rocco, Marco Gobbi, MD, Ph.D., Riccardo Ghio, MD, Ph.D., Yves Pommier, MD, Ph.D., Angelo Michele Carella, MD, Ph.D., Alberto Ballestrero, MD, Ph.D., Silvio Parodi, MD, Ph.D., Franco Patrone, MD, Ph.D., Alessio Nencioni, MD, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2733.
https://doi.org/10.1182/blood.V114.22.2733.2733
Published: 2009